Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases

অনুরূপ উপাদানগুলি

• Impact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer
  অনুযায়ী: Gao, Guanghui, অন্যান্য
  প্রকাশিত: (2019)
• Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer
  অনুযায়ী: Gao, Guanghui, অন্যান্য
  প্রকাশিত: (2019)
• Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer
  অনুযায়ী: Su, Chunxia, অন্যান্য
  প্রকাশিত: (2015)
• Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors
  অনুযায়ী: Liu, Sangtian, অন্যান্য
  প্রকাশিত: (2020)
• Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
  অনুযায়ী: Zhou, Fei, অন্যান্য
  প্রকাশিত: (2020)